References
- Abeyawardne S A., Vale V W., Plant T M. Circulatory concentrations of inhibin during development in the rhesus monkey. 8th International Congress of Endocrinology, KyotoJapan, 1988, Abstract 03–19–077
- Abrahamson P, Lilja H, Falkmer S, et al. Identification of the three predominant prostate secreted proteins and their immunohistochemical localization in normal, hyperplastic and neoplastic prostatic tissue. Eur J Cancer Clin Oncol 1987; 23: 1231, abstract 2
- Doctor V M., Sheth A R., Simha M M., et al. Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 1986; 53: 547–554
- Goldfarb D A., Stein B S., Shamszadeh M, et al. Age related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen. J Urol 1986; 136: 1266–1269
- Li C H., Ramasharma K. Inhibin. Annu Rev Pharmacol Toxico 1987; 127: 1–21
- Santen R J. The testis. Endocrinology and Metabolism, P Felig, J D. Baxter, A E. Broadus, L A. Frohman. McGraw-Hill, New York 1987; 821–905
- Phadke M A., Vijayalakshmi S, Sheth A R. Evidence for the presence of specific receptors for inhibin in human prostate. Indian J Exp Biol 1982; 20: 419–420
- Sathe V S., Sheth N A., Phadke M A., et al. Biosynthesis and localization of inhibin in human prostate. Prostate 1987; 10: 33–43
- Shanbaugh S A., Sheth A R., Nanivadekar S A., et al. Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach. Br J Cancer 1985; 51: 877–882
- Sheth N A., Vanage G R., Hurkadli K S., . Prostate—An extragonadal source of inhibin: Demonstration of inhibin in normal, benign, malignant human prostate and rat prostate by bioassay, radioimmunoassay, immunocytochemical localization and biosynthesis. Inhibins: Chemistry, Measurement and Physiology, A R. Sheth, et al. CRC Press, Boca Raton, FL 1986; Vol II: 109–128
- Sheth N A., Doctor V M., Sampat M B., et al. Inhibinlike material—An immunohistological marker for prostatic origin of metastasis. Can Lett 1987; 36: 93–98
- Sheth A R., Teni T R., Sheth N A. Human prostatic inhibin. Proc 8th Int Congress of Endocrinology, Kyoto, Japan. H Imura, et al. Elsevier, New York 1988; 301–306
- Teni T R., Sheth A R., Kamath M R., et al. Serum and urinary prostatic inhibinlike peptide (PIP) in benign prostatic hyperplasia and carcinoma of prostate. Can Lett 1988, (in press)